BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 30, 2006
View Archived Issues
VaxGen Realizing $129M From Sale Of Ownership In Celltrion
VaxGen Inc. expects to fund its operations through the end of next year by selling its stake in an overseas contract manufacturing firm. (BioWorld Today)
Read More
With Its AMD Drug In Phase III, Genaera Raises $25M Privately
Read More
Radius Licenses SERM Agents With New Mechanism From Eisai
Read More
FuturaGene Using Tolerance Genes To Improve Crop Yield
Read More
Holiday Notice
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Appointments And Advancements
Read More